Fig 1
Pregabalin Capsule
Product Images NDC 80425-0123
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 14 technical images submitted to the FDA as part of the official labeling for Pregabalin (NDC 80425-0123). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Advanced Rx Pharmacy Of Tennessee, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Fig 10
Not available. The text seems to be a jumble of characters and numbers with no coherent meaning or context.*
Fig 11
Fig 12
Fig 2
Fig 3
Fig 4
Fig 5
Fig 6
This text contains data related to different studies where different dosages of a drug were tested against a placebo. The text also mentions that some of the results were found statistically significant when compared to the placebo.*
Fig 7
Fig 9
This appears to be a chart/graph describing the percent of patients who have improved with different doses of Pregabalin in comparison to baseline pain levels. The chart shows Pregabalin at 100 mg and 450 mg daily doses, as well as a 300 mg daily dose of Pregabalin. The data is presented in percentage format with categories such as 0%, 20%, and 100%. The chart also indicates improvement in pain from baseline.*
Formula
This appears to be a formula for calculating a patient's creatinine clearance (CLCr) based on their age, weight, and serum creatinine levels. However, without additional context it is not possible to provide further details on how this calculation would be used or what it indicates about a patient's health.*
Pregabalin 100mg Cap Qty 90 80425 0123
Structure
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
